Calendar Gilead Sciences, Inc.

Equities

GILD

US3755581036

Market Closed - Nasdaq 21:00:00 22/07/2024 BST 5-day change 1st Jan Change
72.41 USD -0.21% Intraday chart for Gilead Sciences, Inc. +2.26% -10.62%

Chart calendar Gilead Sciences, Inc.

b3c8fd2fa2a48a3754c.kpHRfd_2g9KZ7-ZO3IrQf7SESIjVbYBvzcMGfY4uQv0.zci0MJe7y4j3o5U0iLOTO43uO8eNDNEAoalrLclhCYn2p7s1mJzTu_Gj1g~08c9243633df637b16bf82e1fcd68547

Upcoming events on Gilead Sciences, Inc.

08/08/2024 21:02 Q2 2024 Earnings Release
08/08/2024 21:30 Q2 2024 Earnings Call
23/10/2024 Q3 2024 Earnings Release (Projected)
10/02/2025 Q4 2024 Earnings Release (Projected)
23/04/2025 Q1 2025 Earnings Release (Projected)
04/08/2025 Q2 2025 Earnings Release (Projected)

Past events on Gilead Sciences, Inc.

13/06/2024 Détachement de
12/06/2024 18:20 Goldman Sachs Global Healthcare Conference
05/06/2024 16:00 Jefferies Global Healthcare Conference
03/06/2024 19:30 American Society of Clinical Oncology Meeting - Abstract No: #TPS8121
03/06/2024 19:30 American Society of Clinical Oncology Meeting - Abstract No: #8592
03/06/2024 15:00 American Society of Clinical Oncology Meeting - Abstract No: #6531
03/06/2024 14:00 American Society of Clinical Oncology Meeting - Abstract No: #2006
02/06/2024 15:00 American Society of Clinical Oncology Meeting - Abstract No: #TPS4618
02/06/2024 15:00 American Society of Clinical Oncology Meeting - Abstract No: #TPS6130
02/06/2024 15:00 American Society of Clinical Oncology Meeting - Abstract No: #TPS4627
02/06/2024 15:00 American Society of Clinical Oncology Meeting - Abstract No: #TPS1140
02/06/2024 15:00 American Society of Clinical Oncology Meeting - Abstract No: #1102
02/06/2024 15:00 American Society of Clinical Oncology Meeting - Abstract No: #1075
02/06/2024 15:00 American Society of Clinical Oncology Meeting - Abstract No: #1101
02/06/2024 14:00 American Society of Clinical Oncology Meeting - Abstract No: #3508
01/06/2024 21:00 American Society of Clinical Oncology Meeting - Abstract No: #LBA1004
01/06/2024 19:30 American Society of Clinical Oncology Meeting - Abstract No: #TPS4195
01/06/2024 18:30 American Society of Clinical Oncology Meeting - Abstract No: #433248
01/06/2024 15:00 American Society of Clinical Oncology Meeting - Abstract No: #3029
31/05/2024 20:45 American Society of Clinical Oncology Meeting - Abstract No: #LBA8500

Past dividends on Gilead Sciences, Inc.

13/06/2024 Quarterly 0.77 USD
13/03/2024 Quarterly 0.77 USD
13/12/2023 Quarterly 0.75 USD
13/09/2023 Quarterly 0.75 USD
13/06/2023 Quarterly 0.75 USD
13/03/2023 Quarterly 0.75 USD
13/12/2022 Quarterly 0.73 USD
13/09/2022 Quarterly 0.73 USD
13/06/2022 Quarterly 0.73 USD
13/03/2022 Quarterly 0.73 USD

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
22 449
22 305
0.65%
24 689
24 482
0.84%
27 305
26 657
2.43%
27 281
26 518
2.88%
27 116
27 083
0.12%

27 582

EBITDA
Million USD
Released
Forecast
Spread
12 468
13 029
-4.3%
13 184
13 142
0.32%
14 598
15 539
-6.05%
14 283
13 783
3.63%
13 177
13 123
0.41%

9 687

EBIT
Million USD
Released
Forecast
Spread
11 064
11 571
-4.38%
11 704
11 599
0.9%
12 548
13 943
-10.01%
12 180
12 141
0.32%
10 484
10 687
-1.9%

7 253

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
5 160
5 333
-3.24%
1 669
1 636
2.01%
8 278
9 507
-12.92%
5 814
5 658
2.76%
6 859
7 323
-6.33%

1 460

Net income
Million USD
Released
Forecast
Spread
5 386
4 292
25.5%
123
137
-10.03%
6 225
7 205
-13.6%
4 592
4 383
4.77%
5 665
5 872
-3.52%

412

EPS
USD
Released
Forecast
Spread
4,22
3,43
23.14%
0,10
0,12
-16.23%
4,93
5,75
-14.19%
3,64
3,48
4.75%
4,50
4,69
-3.96%

0,34

Announcement Date04/02/2004/02/2101/02/2202/02/2306/02/24-

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales
Million USD
Released
Forecast
Spread
6 590
6 279
4.96%
6 260
5 873
6.6%
7 042
6 133
14.82%
7 389
6 630
11.45%
6 352
6 326
0.41%
6 599
6 454
2.24%
7 051
6 800
3.69%
7 115
7 104
0.16%
6 686
6 349
5.31%

6 708


6 970


7 231


6 485


6 782

EBITDA
Million USD
Released
Forecast
Spread
4 049
3 438
17.79%
3 195
3 183
0.38%
3 811
3 049
24.99%
3 227
2 865
12.63%
2 883
3 407
-15.38%
3 258
3 343
-2.54%
3 908
3 636
7.49%
3 427
3 495
-1.94%

-889


3 365


3 541


3 543







EBIT
Million USD
Released
Forecast
Spread
3 524
3 060
15.15%
2 670
2 602
2.6%
3 286
2 529
29.91%
2 699
2 622
2.92%
2 243
2 658
-15.62%
2 277
2 776
-17.99%
3 224
3 060
5.37%
2 739
2 940
-6.84%
-1 117
-1 679
33.48%

2 703


2 895


2 940


2 587


2 736

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-152
2 158
-107.05%
1 503
1 664
-9.68%
2 432
1 674
45.28%
2 031
1 840
10.37%
1 300
1 900
-31.59%
1 588
1 969
-19.35%
2 318
2 275
1.91%
1 653
2 090
-20.89%
-4 486



1 733


2 077


2 235


2 370


2 465

Net income
Million USD
Released
Forecast
Spread
19,0
1 611
-98.82%
1 144
1 367
-16.32%
1 789
1 248
43.39%
1 640
1 438
14.02%
1 010
1 587
-36.37%
1 045
1 545
-32.38%
2 180
1 801
21.07%
1 429
1 599
-10.66%
-4 170
-2 888
-44.38%

1 370


1 591


1 662


1 662


1 757

EPS
USD
Released
Forecast
Spread
0,02
1,34
-98.5%
0,91
1,11
-17.89%
1,42
1,01
40.93%
1,30
1,15
13%
0,80
1,23
-34.75%
0,83
1,20
-30.93%
1,73
1,43
20.88%
1,14
1,28
-11.05%
-3,34
-1,92
-74.06%

1,11


1,27


1,31


1,24


1,32

Announcement Date28/04/2202/08/2227/10/2202/02/2327/04/2303/08/2307/11/2306/02/2425/04/24-----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. GILD Stock
  4. Calendar Gilead Sciences, Inc.